From: Development and evaluation of oral Cancer quality-of-life questionnaire (QOL-OC)
Characteristics | No. of patients | % |
---|---|---|
Gender | ||
 Male | 139 | 65.3 |
 Female | 74 | 34.7 |
Age | ||
 Mean (SD) | 53.84(10.48) |  |
 Range | 18–86 |  |
Marital status | ||
 Married | 197 | 92.5 |
 Unmarried | 8 | 3.8 |
 Widowed | 5 | 2.3 |
 Divorced | 2 | .9 |
Education level | ||
 Junior high | 73 | 34.3 |
 Senior high | 60 | 28.2 |
 Undergraduate or higher | 41 | 19.2 |
 Primary school or lower | 30 | 14.1 |
 Information missed | 9 | 4.2 |
Cancer site | ||
 Tongue | 51 | 23.9 |
 Buccal mucosa | 29 | 13.6 |
 Gingiva | 25 | 11.7 |
 Salivary glands | 25 | 11.7 |
 Mouth floor | 23 | 10.8 |
 Palate | 23 | 10.8 |
 Multi-sites | 10 | 4.7 |
 Lips | 10 | 4.7 |
 Maxilla/Mandible | 8 | 3.8 |
 Oropharynx | 5 | 2.3 |
 branchial fissure | 1 | .5 |
 Temple | 1 | .5 |
 Maxillary sinus | 1 | .5 |
 Submandibular | 1 | .5 |
Pathological type | ||
 SCC | 144 | 67.6 |
 Mucoepidermoid carcinoma carcinoma | 12 | 5.6 |
 Adenoid cystic | 11 | 5.2 |
 Adenocarcinoma | 6 | 2.8 |
 Pleomorphic adenoma | 4 | 1.9 |
 Other | 30 | 14.6 |
  Ameloblastoma | 1 | .5 |
  Malignant Melanoma | 2 | .9 |
  Hodgkin lymphoma | 1 | .5 |
  Non-Hodgkin lymphoma | 2 | .9 |
  Myoepithelial carcinoma | 3 | 1.4 |
  Basal cell carcinoma | 3 | 1.4 |
  Mesenchymal sarcoma | 1 | .5 |
  Plasma cell sarcoma | 2 | .9 |
  Sarcomatoid carcinoma | 1 | .5 |
  Mesenchymal carcinoma | 2 | .9 |
  Epithelioid vascular endothelium | 1 | .5 |
  Spindle cell sarcoma | 1 | .5 |
  Fibroblastoma | 1 | .5 |
  Acinic cell carcinoma | 4 | 1.9 |
  Adenogenous low-grade malignancy | 3 | 1.4 |
  Dentinogenic ghost cell tumour | 1 | .5 |
  Verrucous carcinoma | 1 | .5 |
  Information missed | 6 | 2.8 |
Treatment | ||
 Surgery | 200 | 93.9 |
 Surgery/radiotherapy | 8 | 3.8 |
 Radiotherapy | 2 | .9 |
 Surgery/radiotherapy/chemotherapy | 1 | .5 |
 Surgery/chemotherapy | 1 | .5 |
 Palliative treatment | 1 | .5 |